Marker Therapeutics
MRKR
MRKR
70 hedge funds and large institutions have $134M invested in Marker Therapeutics in 2019 Q2 according to their latest regulatory filings, with 28 funds opening new positions, 15 increasing their positions, 12 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
70
Holders Change
+14
Holders Change %
+25%
% of All Funds
1.52%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
28
Increased
15
Reduced
12
Closed
14
Calls
$1.02M
Puts
$567K
Net Calls
+$450K
Net Calls Change
+$495K
Top Buyers
| 1 |
BlackRock
New York
|
+$12.9M |
| 2 |
State Street
Boston,
Massachusetts
|
+$3.77M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$1.57M |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$1.09M |
| 5 |
OCM
Osterweis Capital Management
San Francisco,
California
|
+$945K |
Top Sellers
| 1 |
6CM
683 Capital Management
New York
|
-$7.13M |
| 2 |
LCM
Laurion Capital Management
New York
|
-$1.4M |
| 3 |
Millennium Management
New York
|
-$1.17M |
| 4 |
Barclays
London,
United Kingdom
|
-$811K |
| 5 |
Goldman Sachs
New York
|
-$474K |
